NCT07107750 2026-02-04Emavusertib (CA-4948) in Combination With Cisplatin, Gemcitabine, and Durvalumab in Patients With Untreated Advanced or Metastatic Biliary Tract CancerWashington University School of MedicinePhase 1 Not yet recruiting48 enrolled